Imatinib For Treatment of Multifocal Maxillofacial Giant Cell Lesions: A Case Series
Maxillofacial giant cell lesions (MGCLs) can lead to disfigurement and functional impairments. Management often involves a combination of operative and nonoperative strategies. This case series presents the first reported use of imatinib for multifocal MGCLs in a patient with Noonan syndrome, alongside 2 patients with cherubism.
Authors
- Sarah Ehling (ORCID: https://orcid.org/0000-0001-5114-9946)
- Aparna Bhat (ORCID: https://orcid.org/0000-0003-2836-2786)
- Kevin G. Gard
- Mark A. Egbert (ORCID: https://orcid.org/0000-0002-1215-1127)
- Jesse T. Han (ORCID: https://orcid.org/0000-0002-9173-0089)
- Tyler Garrett Ketterl (ORCID: https://orcid.org/0000-0003-2359-473X)
Institutions
- Seattle Children's Hospital (US)
- University of Washington (US)
- Seattle Children's Hospital (US)
- Center for Cancer and Blood Disorders (US)
- National Medical Research Center of Dentistry and Maxillofacial Surgery (RU)
Publication Details
- Journal
- Journal of Pediatric Hematology/Oncology
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1097/mph.0000000000003087
- Primary Topic
- Histiocytic Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00